STAT will host a webinar on 22 January 2019 on the future of clinical trials.
The randomized controlled trial is the gold standard when it comes to developing new drugs, but it's expensive, time-consuming, and, in some cases, not even possible. So, with encouragement from the U.S. Food and Drug Administration (FDA), the drug industry is advancing efforts to modernize clinical trials, streamlining the process of figuring out whether a treatment actually works.
The webinar will delve into new approaches, examine case studies, and better understand the future of clinical trials.
To register for the webinar, click here.